Vera Therapeutics (VERA) PT Raised to $66 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Dina Ramadane raised the price target on Vera Therapeutics (NASDAQ: VERA) to $66.00 (from $48.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
